Streptomyces sp. RAB12 having potential to produce novel actinomycin group compounds was isolated from soil samples collected from CSIR-Indian Institute of Chemical Technology, Hyderabad, India, garden premises using International Streptomycetes Project (ISP) protocols. The 16S rRNA sequence of the strain RAB12 exhibited identity with Streptomyces sp. 13647M and the sequence was deposited in NCBI under the accession number KY 203650 while the strain RAB12 was deposited in The Microbial Type Culture Collection and Gene Bank (MTCC) with accession number MTCC 12747. Cell-free extract of this novel strain revealed two bioactive principles viz., RSP 01 and RSP 02. HR-MS analysis indicated a molecular mass of 1269.61 and 1270.63 m/z g/mol for RSP 01 and RSP 02, respectively. Proton H,C NMR, 2D NMR and mass spectroscopy analysis revealed a similar fingerprint to that actinomycin D except for a peak at δH3.59 J (H NMR) and δ 208.88 (C NMR) for RSP 01 compound suggesting the presence of keto carbonyl at 5-oxo position on the proline moiety which is absent in actinomycin D. Purified RSP 02 depicted a similarity with RSP 01 except a peak in the H proton NMR at δH 3.81 J. HR-ESI mass spectra confirmed the molecular formulae for RSP 01 and RSP 02 as CHNO and CHNO, respectively. Antimicrobial activity profile revealed higher antimicrobial activity against bacterial strains (Pseudomonas aeruginosa, Micrococcus luteus, Staphylococcus aureus, Salmonella typhi, and Bacillus subtilis) and Candida albicans compared to standard actinomycin D. MIC and MBC for RSP 01 were observed to be 0.0039 and 0.0078 (μg/ml) against C. albicans, while for actinomycin D, it was found to be 0.031 and 0.62 (μg/ml), respectively indicating a tenfold higher potency. Thus, these RSP 01 and RSP 02 compounds from Streptomyces sp. RAB12 may be promising candidates for industrial and clinical applications.

Augmenting value-added products generation with the biorefinery process of sugar cane by utilizing the by-products helps to achieve a more sustainable model of the sugarcane industry and in turn, contributes to the circular economy. Among the value-added products produced from sugarcane waste, functional foods offer additional health benefits besides their nutritional and calorific value. In recent years non-digestible sugars gained interest as potential prebiotic functional foods which benefit the host without increasing calorific value. These sugars are produced by the breakdown of carbohydrate polymers like cellulose and xylan, by thermochemical treatment or by enzymatic hydrolysis, or a combination of both. Sugar cane bagasse (SB) is an economical source of xylan which can serve as the substrate for xylooligosaccharides (XOS), xylobiose, xylitol, and ethanol. Cellulases, xylanases, and ligninases have wide applications in food processing, agro-fiber, pharmaceutical, and the paper and pulp industries including nutraceuticals production, where these enzymes provide eco-friendly alternatives to some chemical processes and help to reduce environmental impact. Conventional thermochemical methods for nutraceuticals production require chemicals that result in the release of toxic byproducts thus requiring additional steps for refining. In this context, the sustainable and eco-friendly processes for the production of nutraceuticals require employing biocatalysts like microbial enzymes or microbes as a whole, where in addition to averting the toxic byproducts the refining process requires lesser steps. The present chapter discusses the current research and challenges in the production of value-added products from sugarcane byproducts and their contribution to the sustainability of the sugarcane industry.